{
  "node_id": "us-fda-21-cfr-600-biological-products-general-standards",
  "title": "21 CFR Part 600 - FDA Biological Products: General Standards, Records and Reporting",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.0",
  "last_updated": "2026-05-24",
  "bluf": "21 CFR Part 600 sets the general standards applicable to licensed biological products regulated by the U.S. Food and Drug Administration through the Center for Biologics Evaluation and Research…",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "us_primary_law",
      "related_instruments",
      "key_prohibitions",
      "enforcement"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "dependencies": [
    "us-fda-21-cfr-606-cgmp-blood-and-blood-components",
    "us-fda-21-cfr-203-prescription-drug-marketing",
    "us-fda-21-cfr-807-device-establishment-registration-listing-510k"
  ],
  "primary_citations_count": 9,
  "workflow_steps_count": 8,
  "schema_fields_count": 8,
  "citation_preview": [
    "Public Health Service Act, 42 U.S.C. 262, and Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 301 et seq. - statutory authority",
    "21 CFR Part 600, § 600.10 - personnel"
  ]
}